{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:34:29Z","timestamp":1794108869211,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU52PS910232"],"award-info":[{"award-number":["NU52PS910232"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01413-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:17:02Z","timestamp":1770826622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug checking services: barriers and facilitators to implementation by U.S. syringe services programs"],"prefix":"10.1186","volume":"23","author":[{"given":"Jessica","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Margaret","family":"Philbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hairgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Kral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrot H.","family":"Lambdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"12","key":"1413_CR1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0277-9536(00)00109-X","volume":"51","author":"FI Bastos","year":"2000","unstructured":"Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51(12):1771\u201382.","journal-title":"Soc Sci Med"},{"issue":"2","key":"1413_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1057\/jphp.2014.54","volume":"36","author":"H Bramson","year":"2015","unstructured":"Bramson H, Des Jarlais DC, Arasteh K, Nugent A, Guardino V, Feelemyer J, et al. State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness. J Public Health Policy. 2015;36(2):212\u201330.","journal-title":"J Public Health Policy"},{"issue":"1","key":"1413_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarcao J, Torre C, et al. Effectiveness of needle and syringe Programmes in people who inject drugs\u2014an overview of systematic reviews. BMC Public Health. 2017;17(1):309.","journal-title":"BMC Public Health"},{"key":"1413_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.trsl.2021.03.011","volume":"234","author":"LD Wenger","year":"2021","unstructured":"Wenger LD, Kral AH, Bluthenthal RN, Morris T, Ongais L, Lambdin BH. Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises. Transl Res. 2021;234:159\u201373.","journal-title":"Transl Res"},{"key":"1413_CR5","unstructured":"U.S. Centers for Disease Control and Prevention. Understanding the opioid overdose epidemic Atlanta, GA: Centers for Disease Control and Prevention; 2024 [Updated Apr 5. Available from: https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html."},{"issue":"7","key":"1413_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJMp1615145","volume":"376","author":"RG Frank","year":"2017","unstructured":"Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376(7):605\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"1413_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0625-0","volume":"9","author":"Y Han","year":"2019","unstructured":"Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9(1):282.","journal-title":"Transl Psychiatry"},{"key":"1413_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.drugalcdep.2018.10.017","volume":"194","author":"JL Glick","year":"2019","unstructured":"Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: results from a multi-site study. Drug Alcohol Depend. 2019;194:527\u201332.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"1413_CR9","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/add.16318","volume":"118","author":"J Friedman","year":"2023","unstructured":"Friedman J, Shover CL. Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021. Addiction. 2023;118(12):2477\u201385.","journal-title":"Addiction"},{"issue":"1","key":"1413_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0179-5","volume":"14","author":"L Harper","year":"2017","unstructured":"Harper L, Powell J, Pijl EM. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017;14(1):52.","journal-title":"Harm Reduct J"},{"key":"1413_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugpo.2018.10.001","volume":"62","author":"MK Laing","year":"2018","unstructured":"Laing MK, Tupper KW, Fairbairn N. Drug checking as a potential strategic overdose response in the fentanyl era. Int J Drug Policy. 2018;62:59\u201366.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1413_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/02791072.2022.2028203","volume":"55","author":"F Giulini","year":"2023","unstructured":"Giulini F, Keenan E, Killeen N, Ivers JH. A systematized review of drug-checking and related considerations for implementation as a harm reduction intervention. J Psychoact Drugs. 2023;55(1):85\u201393.","journal-title":"J Psychoact Drugs"},{"issue":"3","key":"1413_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344.","journal-title":"Addiction"},{"issue":"1","key":"1413_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11243-4","volume":"21","author":"B Wallace","year":"2021","unstructured":"Wallace B, van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021;21(1):1156.","journal-title":"BMC Public Health"},{"issue":"1","key":"1413_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01014-w","volume":"21","author":"L Moran","year":"2024","unstructured":"Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, et al. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Harm Reduct J. 2024;21(1):92.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1413_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-020-00373-4","volume":"17","author":"B Wallace","year":"2020","unstructured":"Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, et al. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17(1):29.","journal-title":"Harm Reduct J"},{"key":"1413_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104560","volume":"132","author":"KL Chayama","year":"2024","unstructured":"Chayama KL, Ti L, Arredondo Sanchez Lira J, Coulaud P-j, Bardwell G, Knight R. Opportunities and challenges for implementing drug checking services in British Columbia, Canada: a qualitative study. Int J Drug Policy. 2024;132:104560.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1413_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00590-7","volume":"19","author":"D Falzon","year":"2024","unstructured":"Falzon D, Carver H, Masterton W, Wallace B, Sumnall H, Measham F, et al. Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Subst Abuse Treat Prev Policy. 2024;19(1):7.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1413_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The bronze age of drug checking:\u00a0barriers and facilitators to implementing\u00a0advanced drug checking amidst police violence and COVID-19. Harm Reduct J. 2022;19(1):9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1413_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00882-y","volume":"20","author":"C Grace Rose","year":"2023","unstructured":"Grace Rose C, Pickard AS, Kulbokas V, Hoferka S, Friedman K, Epstein J, et al. A qualitative assessment of key considerations for drug checking service implementation. Harm Reduct J. 2023;20(1):151.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1413_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00856-0","volume":"20","author":"C Grace Rose","year":"2023","unstructured":"Grace Rose C, Kulbokas V, Carkovic E, Lee TA, Pickard AS. Contextual factors affecting the implementation of drug checking for harm reduction: a scoping literature review from a North American perspective. Harm Reduct J. 2023;20(1):124.","journal-title":"Harm Reduct J"},{"key":"1413_CR22","unstructured":"U.S. Centers for Disease Control and Prevention. US overdose deaths decrease almost 27% in 2024. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2025\/20250514 htm#:~: text. 2025;27:25."},{"key":"1413_CR23","doi-asserted-by":"crossref","unstructured":"Garnett MF, Mini\u00f1o AM. Drug overdose deaths in the United States, 2003\u20132023. 2024.","DOI":"10.15620\/cdc\/170565"},{"issue":"3","key":"1413_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/1049732317697102","volume":"28","author":"J Phillippi","year":"2018","unstructured":"Phillippi J, Lauderdale J. A guide to field notes for qualitative research: context and conversation. Qual Health Res. 2018;28(3):381\u20138.","journal-title":"Qual Health Res"},{"issue":"2","key":"1413_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1413_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241244856","volume":"23","author":"ST Fife","year":"2024","unstructured":"Fife ST, Gossner JD. Deductive qualitative analysis: evaluating, expanding, and refining theory. Int J Qual Methods. 2024;23:16094069241244856.","journal-title":"Int J Qual Methods"},{"key":"1413_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241289279","volume":"23","author":"M Michelen","year":"2024","unstructured":"Michelen M, Phan M, Zimmer A, Coury N, Morey B, Montiel Hernandez G, et al. Practical qualitative data analysis for public health research: a guide to a team-based approach with flexible coding. Int J Qual Methods. 2024;23:16094069241289279.","journal-title":"Int J Qual Methods"},{"issue":"1","key":"1413_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"issue":"1","key":"1413_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01073-z","volume":"21","author":"E Healy","year":"2024","unstructured":"Healy E, Means AR, Knudtson K, Frank N, Juarez A, Prohaska S, et al. Facilitators and barriers to monitoring and evaluation at syringe service programs. Harm Reduct J. 2024;21(1):157.","journal-title":"Harm Reduct J"},{"key":"1413_CR30","doi-asserted-by":"publisher","first-page":"100421","DOI":"10.1016\/j.ssmqr.2024.100421","volume":"5","author":"CF Akiba","year":"2024","unstructured":"Akiba CF, Smith J, Wenger LD, Morris T, Patel SV, Bluthenthal RN, et al. Financial barriers, facilitators, and strategies among syringe services programs in the US, and their impact on implementation and health outcomes. SSM Qual Res Health. 2024;5:100421.","journal-title":"SSM Qual Res Health."},{"key":"1413_CR31","unstructured":"Office of National Drug Control Policy. Biden-Harris administration actions to address the overdose epidemic Washington, D.C.: The White House; 2024 [Available from: https:\/\/bidenwhitehouse.archives.gov\/ondcp\/the-administrations-strategy\/biden-harris-administration-actions-to-address-the-overdose-epidemic\/."},{"issue":"2","key":"1413_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/09687637.2012.743506","volume":"20","author":"C Lloyd","year":"2013","unstructured":"Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs Educ Prev Policy. 2013;20(2):85\u201395.","journal-title":"Drugs Educ Prev Policy"},{"key":"1413_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.drugpo.2015.08.018","volume":"27","author":"C Treloar","year":"2016","unstructured":"Treloar C, Rance J, Yates K, Mao L. Trust and people who inject drugs: the perspectives of clients and staff of needle syringe programs. Int J Drug Policy. 2016;27:138\u201345.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1413_CR34","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.amepre.2021.05.044","volume":"61","author":"D Broz","year":"2021","unstructured":"Broz D, Carnes N, Chapin-Bardales J, Des Jarlais DC, Handanagic S, Jones CM, et al. Syringe services programs\u2019 role in ending the HIV epidemic in the US: why we cannot do it without them. Am J Prev Med. 2021;61(5):S118\u201329.","journal-title":"Am J Prev Med"},{"key":"1413_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","volume":"70","author":"CM Jones","year":"2019","unstructured":"Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the US. Int J Drug Policy. 2019;70:22\u201332.","journal-title":"Int J Drug Policy"},{"key":"1413_CR36","unstructured":"Washington State Community Drug Checking Network. Washington State Community Drug Checking Network: Addictions Drug and Alcohol Institute, University of Washington; 2023 [Available from: https:\/\/adai.uw.edu\/wordpress\/wp-content\/uploads\/THE_DC_Network_Infosheet.pdf."},{"key":"1413_CR37","unstructured":"ACR Health. New York State Department of Health announces Drug Checking Program Syracuse, NY: ACR Health; 2023 [updated Oct 23. Available from: https:\/\/www.acrhealth.org\/new-york-state-department-of-health-announces-drug-checking-program\/."},{"issue":"Suppl 6","key":"1413_CR38","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1097\/PHH.0000000000001581","volume":"28","author":"TC Green","year":"2022","unstructured":"Green TC, Olson R, Jarczyk C, Erowid E, Erowid F, Thyssen S, et al. Implementation and uptake of the Massachusetts drug supply data stream: a statewide public health-public safety partnership drug checking program. J Public Health Manag Pract. 2022;28(Suppl 6):S347\u201354.","journal-title":"J Public Health Manag Pract"},{"issue":"1","key":"1413_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01256-x","volume":"17","author":"EL Crable","year":"2022","unstructured":"Crable EL, Lengnick-Hall R, Stadnick NA, Moullin JC, Aarons GA. Where is \u201cpolicy\u201d in dissemination and implementation science? Recommendations to advance theories, models, and frameworks: EPIS as a case example. Implement Sci. 2022;17(1):80.","journal-title":"Implement Sci"},{"key":"1413_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.111028","volume":"253","author":"JA Cepeda","year":"2023","unstructured":"Cepeda JA, Thompson E, Ujeneza M, Tardif J, Walsh T, Morales A, et al. Costing analysis of a point-of-care drug checking program in Rhode Island. Drug Alcohol Depend. 2023;253:111028.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1413_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","volume":"114","author":"SN Facente","year":"2024","unstructured":"Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, et al. Funding and delivery of syringe services programs in the United States, 2022. Am J Public Health. 2024;114(4):435\u201343.","journal-title":"Am J Public Health"},{"issue":"3","key":"1413_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15381500802307492","volume":"7","author":"HK Belani","year":"2008","unstructured":"Belani HK, Muennig PA. Cost-effectiveness of needle and syringe exchange for the prevention of HIV in New York City. J HIV\/AIDS Soc Serv. 2008;7(3):229\u201340.","journal-title":"J HIV\/AIDS Soc Serv"},{"issue":"2","key":"1413_CR43","first-page":"137","volume":"27","author":"SC Ijioma","year":"2021","unstructured":"Ijioma SC, Pontinha VM, Holdford DA, Carroll NV. Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree. J Manag Care Spec Pharm. 2021;27(2):137\u201346.","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"1413_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/00220426221108694","volume":"53","author":"HD Montaque","year":"2023","unstructured":"Montaque HD, Christenson E, Spector A, Wogen J, McDonald M, Weeks MR, et al. Mechanisms for expanding harm reduction for opioid use in suburban and rural US settings. J Drug Issues. 2023;53(2):196\u2013212.","journal-title":"J Drug Issues"},{"issue":"1","key":"1413_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00755-4","volume":"20","author":"BH Lambdin","year":"2023","unstructured":"Lambdin BH, Wenger L, Bluthenthal R, Bartholomew TS, Tookes HE, LaKosky P, et al. How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study. Harm Reduct J. 2023;20(1):26.","journal-title":"Harm Reduct J"},{"key":"1413_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104419","volume":"127","author":"G Kolla","year":"2024","unstructured":"Kolla G, Khorasheh T, Dodd Z, Greig S, Altenberg J, Perreault Y, et al. \u201cEverybody is impacted. Everybody\u2019s hurting\u201d: grief, loss and the emotional impacts of overdose on harm reduction workers. Int J Drug Policy. 2024;127:104419.","journal-title":"Int J Drug Policy"},{"key":"1413_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104206","volume":"121","author":"JN Park","year":"2023","unstructured":"Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. A survey of North American drug checking services operating in 2022. Int J Drug Policy. 2023;121:104206.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"1413_CR48","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.2105\/AJPH.2019.305268","volume":"109","author":"CS Davis","year":"2019","unstructured":"Davis CS, Carr DH, Samuels EA. Paraphernalia laws, criminalizing possession and distribution of items used to consume illicit drugs, and injection-related harm. Am J Public Health. 2019;109(11):1564\u20137.","journal-title":"Am J Public Health"},{"key":"1413_CR49","volume-title":"Repeal of paraphernalia laws: Minnesota leads the way","author":"C Davis","year":"2023","unstructured":"Davis C. Repeal of paraphernalia laws: Minnesota leads the way. Edina, MN: Network for Public Health Law; 2023."},{"key":"1413_CR50","unstructured":"Network for Public Health Law. Harm reduction and overdose prevention: 50-State Survey. Legality of drug checking equipment in the United States. Edina, MN: Network for Public Health Law; 2023."},{"issue":"5","key":"1413_CR51","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1524839917742850","volume":"19","author":"CR Story","year":"2018","unstructured":"Story CR, Members of the Southern Harm Reduction C, Kao WK, Currin J, Brown C, Charles V. Evaluation of the southern harm reduction coalition for HIV prevention: advocacy accomplishments. Health Promot Pract. 2018;19(5):695\u2013703.","journal-title":"Health Promot Pract"},{"issue":"3","key":"1413_CR52","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11904-018-0397-9","volume":"15","author":"DH Cloud","year":"2018","unstructured":"Cloud DH, Castillo T, Brinkley-Rubinstein L, Dubey M, Childs R. Syringe decriminalization advocacy in red states: lessons from the North Carolina Harm Reduction Coalition. Curr HIV AIDS Rep. 2018;15(3):276\u201382.","journal-title":"Curr HIV AIDS Rep"},{"key":"1413_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108976","volume":"228","author":"L Karch","year":"2021","unstructured":"Karch L, Tobias S, Schmidt C, Doe-Simkins M, Carter N, Salisbury-Afshar E, et al. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA. Drug Alcohol Depend. 2021;228:108976.","journal-title":"Drug Alcohol Depend"},{"key":"1413_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0437-z","volume":"11","author":"MA Kirk","year":"2016","unstructured":"Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the consolidated framework for implementation research. Implement Sci. 2016;11:72.","journal-title":"Implement Sci"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01413-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:02:42Z","timestamp":1773831762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01413-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01413-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at RTI International approved all study procedures and determined this study to be research not involving human subjects given the focus on SSP operations (STUDY00022309).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}